Start / Docs Who Lift / Flow trial and glp 1 cost rant

FLOW trial and GLP-1 cost rant

46 min • 4 juni 2024

Drs. Karl and Spencer discuss the recent FLOW trial where semaglutide was found to be kidney protective. They also go off about the costs of these medicines and what to do (including compounding considerations).

Click here to see the study

Senaste avsnitt

Clinical vs Anthropometric Obesity

2 juli | 32 min

GLP-1 meds and macular degeneration

23 juni | 34 min

Menopause, MHT, and GLP-1 medicines

12 juni | 28 min

The Science of Myostatin inhibitors, GLP-1 meds and Muscle Mass

6 juni | 28 min

Current State of Nutrition Research and MAHA

29 maj | 56 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00